Bruker acquires Vutara optical imaging

Bruker Corporation of Billerica, Mass., has announced that the provider of instrumentation for biomedical research has acquired Vutara Incorporated, producers of high-speed and resolution 3D fluorescence microscopy.

Vutara brings to Bruker very high resolution single-molecular localization microscopy for cellular and molecular research. This will add to Bruker’s stake in confocal fluorescence and atomic force microscopes.

“Super-resolution microscopy is emerging as a critical requirement for our customers, and being able to integrate Vutara’s best-in-class high-speed, 3D super-resolution systems with our line of multi-photon and multi-point scanning optical microscopy technologies will provide a significant benefit to the research community,” said Mark R. Munch, PhD, president of the Bruker MAT Group. “Achieving video-rate time resolution, higher spatial resolution, all with improved ease of use, is generating considerable excitement in this rapidly growing area, and this is exactly what Vutara brings to Bruker’s customers with its proprietary technology.”

Vutara, based in Salt Lake City, Utah, expects $2 million in revenue for 2014. Further details of the sale and acquisition were not disclosed.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.